Picture of Sedana Medical AB (publ) logo

SEDANA Sedana Medical AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Brief: Sedana Medical Gets Positive Opinion From EMA's Pediatric Committee On Reduced Pediatric Study Design

Dec 23 (Reuters) - Sedana Medical AB (publ)  SEDANA.ST :
    * SEDANA MEDICAL RECEIVES POSITIVE OPINION FROM EMA'S
PEDIATRIC
COMMITTEE ON REDUCED PEDIATRIC STUDY DESIGN
    * CHANGE WILL ENABLE FASTER STUDY COMPLETION, EARLIER
APPROVAL OF
PEDIATRIC INDICATION AND REDUCED INVESTMENTS
    * EXPECTS TO CONCLUDE STUDY BASED ON APPROXIMATELY 90
PATIENTS,
INSTEAD OF 160 PATIENTS PREVIOUSLY.
    * NOW EXPECTS EUROPEAN APPROVAL OF PEDIATRIC INDICATION IN A
DECENTRALIZED PROCEDURE IN Q4 2023 OR Q1 2024

Source text for Eikon:  ID:nWkr3lwVP2 
Further company coverage:  SEDANA.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Sedana Medical AB (publ)

See all news